HGH-fragment 176-191 CAS:221231-10-3

Growth Hormone peptide fragment 176-191, also known as HGH Frag 176-191, is a modified form of amino acids 176-191 of the GH polypeptide. Investigators at Monash University discovered that the fat-reducing effects of GH appear to be controlled by a small region near one end of the Growth Hormone molecule. This region, which consists of amino acids 176-191, is less than 10% of the total size of the GH molecule and appears to have no effect on growth or insulin resistance. It works by mimicking the way natural Growth Hormone regulates fat metabolism but without the adverse effects on blood sugar or growth that is seen with unmodified Growth Hormone. Like Growth Hormone, the HGH fragment 176-191 stimulates lipolysis (the breakdown or destruction of fat) and inhibits lipogenesis (the transformation of nonfat food materials into body fat) both in laboratory testing and in animals and humans.

HGH-fragment 176-191 Functions and Traits

HGH-fragment 176-191 is the end of the 191-amino acid Human Growth Hormone molecular chain. GH is a hormone produced by the pituitary. HGH is the synthetic version produced in a lab; both are comprised of the same 191-amino acid chain. GH, in particular elevated levels through the use of HGH have long been associated with fat loss. They have also been associated with increases in muscularity, recovery and a host of health and anti-aging benefits. For HGH Frag 176-191, the concentration of action is only on the adipose fat cells, specifically by increasing lipolitic action.

HGH Frag 176-191 has been shown to be such an effective fat loss tool it actually inhibits the formation of lipids and fatty acids. Equally important, as it is only a portion of the full GH hormone, the issues of hyperglycemia often associated with HGH use are absent. This means there is no blood sugar issues as can occur at times with HGH.